All posts

Follow Us

LinkedInInstagramX
Quarterly ResultsArchiveLast updated 7 November 20262 min read

Mukka Proteins (MUKKA) Q2 FY27 Profit Slips 5% QoQ Even as Revenue Doubles

Mukka Proteins' Q2 revenue more than doubled year-on-year, but profit dipped sequentially as margin pressure and a heavy debt load weighed on the bottom line.

By Anant Kacholia, HexaWealth Research · Created 7 November 2026

Mukka Proteins reported a 108% YoY surge in Q2 FY27 revenue to ₹509 crore, yet net profit fell 5% from the previous quarter. The fishmeal producer faces margin pressure from rising costs and high debt, even as new international capacity comes online.

For Mukka Proteins, a leading fishmeal and fish oil producer, the September quarter was a story of scale and strain. Revenue more than doubled from a year ago, yet profit slipped from the prior quarter as the costs of rapid expansion and high leverage began to show.

The numbers tell both sides of the story. Revenue reached ₹508.9 crore, up 108% from a weak Q2 last year and 4% from the June quarter. Net profit, however, declined 5% sequentially to ₹17.7 crore. The net profit margin dipped 30 basis points to 3.5%.

Revenue & profit

Revenue (₹ Cr)

Profit (₹ Cr)

Net Profit Margin

MetricCurrentQ2 FY27PreviousQ1 FY27Same quarter LYQ2 FY26
Revenue (₹ Cr)
508.87YoY +108%
489.65
244.58
Profit (₹ Cr)
17.73YoY +158%
18.63
6.88
Net Profit Margin
3.5%YoY +25%
3.8%
2.8%

The margin squeeze beneath the top-line surge

Strong global demand for aquafeed drove the revenue surge, as noted by Sahi Markets. Yet profitability was pinched. According to FlashFinance, operating profit margin fell 149 basis points quarter-on-quarter. Rising interest costs, up 4% QoQ, and a near five-fold jump in other income—which FlashFinance flagged as a one-off item—masked underlying pressure.

A balance sheet stretched for growth

The company's aggressive growth is funded heavily by debt. Borrowings stood at ₹779 crore at the end of FY26, resulting in a debt-to-equity ratio of 1.54. This high leverage, as highlighted by InvestorFeed, directly pressures profits through finance costs of ₹303.5 crore last year. The company is raising more capital, having allotted ₹47 crore in convertible warrants in Q2.

The geographic hedge now in play

A key strategic move is the new Oman facility. Its subsidiary, United Gulf Fishery Products LLC, began commercial production in October. Sahi Markets reports this is a structural hedge against seasonal fish catch volatility in India, aiming to provide year-round raw material supply and stabilize costs.

Key Points

  • Revenue crossed ₹500 crore, more than doubling year-on-year, but quarterly profit growth stalled.
  • High financial leverage, with a debt-to-equity ratio of 1.54, continues to pressure margins through elevated interest costs.
  • The commencement of the Oman manufacturing facility provides a geographic hedge against India's seasonal raw material supply risks.
  • The company's trailing-twelve-month net profit margin of 4.2% remains above the latest quarter's 3.5%, indicating recent margin compression.

Hexa Perspective

Mukka Proteins is executing a high-wire act: scaling revenue rapidly in a favorable market while managing the financial strain of that growth. The new Oman plant could ease raw material volatility, a critical risk. Yet, the path to sustained profitability hinges on converting top-line momentum into operating leverage, which remains challenged by its capital structure. Investors are weighing the promise of geographic diversification against the reality of a balance sheet stretched thin.

Share or follow HexaWealth

Also read

Want this applied to your portfolio?

Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.

Mukka Proteins (MUKKA) Q2 FY27 results, revenue and profits.

Frequently asked questions

What were Mukka Proteins' Q2 FY27 results?
Mukka Proteins reported Q2 FY27 revenue of ₹508.87 crore and a net profit of ₹17.73 crore for the quarter ended September 2026. Revenue more than doubled year-on-year, but profit declined by about 5% compared to the previous June quarter.
Why did Mukka Proteins' Q2 profit dip despite higher revenue?
Mukka Proteins' Q2 FY27 profit dipped 5% quarter-on-quarter due to margin pressure. Operating profit margin contracted, and while other income provided a one-off boost, rising interest costs from high debt levels weighed on the bottom line.
What is Mukka Proteins' debt situation?
Mukka Proteins has a high debt load, with a debt-to-equity ratio of 1.54 as of FY26 end. Total borrowings were ₹779 crore. This leverage results in significant interest costs, which pressure profitability as the company expands.
What is the significance of Mukka Proteins' Oman facility?
Mukka Proteins' Oman subsidiary, United Gulf Fishery Products LLC, began commercial production in October 2026. According to Sahi Markets, this facility is a strategic hedge to mitigate seasonal raw material supply risks from India's fishing cycles.
What was Mukka Proteins' net profit margin in Q2 FY27?
Mukka Proteins' net profit margin was 3.5% in Q2 FY27. This represents a 30 basis point decline from the previous quarter's margin of 3.8%, reflecting the profitability squeeze during the period.
How did Mukka Proteins' revenue perform year-on-year in Q2?
Mukka Proteins' revenue grew 108.1% year-on-year in Q2 FY27, rising from ₹244.58 crore in Q2 FY26 to ₹508.87 crore. This doubling of sales was driven by strong demand in the global aquafeed market.
What are the key risks for Mukka Proteins?
Key risks include volatile raw material (fish) prices and seasonal catch availability, high working capital intensity due to inventory, and foreign exchange fluctuations from its export business, as highlighted by Sahi Markets.
Did Mukka Proteins' results beat analyst estimates?
Available reports from Sahi Markets and Scanx.trade highlight the strong year-on-year growth but do not specify consensus estimates. FlashFinance noted the company's profit was 29% above its own historical trend for the quarter.
What is Mukka Proteins' capacity expansion plan?
Mukka Proteins is expanding its Bengaluru wet waste bioconversion capacity to 1,000 tonnes per day by December 2027. It has also acquired stakes in Delta Marine and is investing in its new Oman facility to boost production.
What is Mukka Proteins' shareholding pattern?
As of September 2026, promoters hold 73.33% of Mukka Proteins. Foreign institutional investors own 1.7%, domestic institutions hold 0.2%, and the public holds the remaining 24.77%, according to SectorAlpha.
Mukka Proteins Q2 FY27 results August 2026
Mukka Proteins announced its Q2 FY27 results for the period ending September 2026 in November 2026. The company reported revenue of ₹508.87 crore and a net profit of ₹17.73 crore for the quarter.
Why did Mukka Proteins profits plunge despite higher sales?
Mukka Proteins' profit dipped 5% quarter-on-quarter in Q2 FY27 despite higher sales due to margin compression. Rising costs, including interest expenses from high debt, offset the benefits of revenue growth.